Prostate Cancer

The Future of Molecular Imaging and Prostate Cancer

Because treatment for prostate cancer is highly individualized, molecular imaging technologies are helping to improve the ways in which prostate cancer is diagnosed and treated.

How Lack of Access to Prostate Care Determines Outcomes of Underserved Populations

When it comes to medical care, many factors can determine the types of treatment and medications that are available to patients. Often times, populations with less access to adequate care, particularly with regards to specialized treatment for diseases like prostate cancer, may experience poorer outcomes.

On the Cusp: Straddling the Emotional & Physical Reality of a Prostate Cancer Diagnosis

A year ago, long-time San Franciscan and hospitality entrepreneur Chip Conley received a shocking diagnosis - he had intermediate-stage prostate cancer.

The Hidden Role of Radiologists in Prostate Cancer Treatment, Research, and Support

With over 15 of experience in radiology, and as an internationally-recognized expert in the use of imaging for the detection and treatment of genitourinary diseases such as prostate cancer, Antonio Westphalen, MD considers the role radiologists play in overall patient care significant.

UCSF Radiology Hosts #UCSFRadChat During Prostate Cancer Awareness Month

In September, UCSF Radiology hosted a Live Twitter chat on prostate cancer - advances in diagnosis and treatment and what the community wants to know. The event coincided with Prostate Cancer Awareness Month. 

#UCSFRadChat: Eyes on Prostate Health – Join us!

To amplify and continue the great conversation following the prostate cancer awareness event, UCSF Radiology (@UCSFimaging) will be hosting a Twitter Chat on Tuesday, September 24 from 12 – 12:45 PM PDT to coincide with Prostate Cancer Awareness Month. 

Scientists at UCSF Study Impact of 68Ga-PSMA-11 PET on Post Radical Prostatectomy (RP) Salvage Radiotherapy

Recently, scientists from the UC San Francisco Departments of Radiology and Biomedical Imaging, Urology and Radiation Oncology came together to study the impact of 68Ga-PSMA-11 PET on post radical prostatectomy (RP) salvage radiotherapy.

Researchers Assess the Accuracy of 68Ga-PSMA-11 PET in Localizing Prostate Cancer

Scientists at UCSF and UCLA designed a single-arm prospective trial on 635 patients with biochemically recurrent prostate cancer to assess the accuracy of 68Ga-PSMA-11 PET.

Results of Phase I of CTT1057 Human Clinical Trial for Prostate Cancer Now Published

Scientists at UC San Francisco have just conducted the first-in-human Phase I study of CTT1057 in patients with localized and metastatic prostate cancer.

Tackling Prostate Cancer with Innovative Imaging Techniques

For John Kurhanewicz, PhD, and other researchers at UCSF, it’s important to work in an environment that not only supports their research, but provides the funding necessary for equipment and technological resources.